Latest Breaking News On - Thomas schneckenburger - Page 18 : comparemela.com
Molecular Partners and Novartis Announce Inclusion of COVID-19 Antiviral Candidate, ensovibep, in NIH-Sponsored ACTIV-3 Trial
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
Molecular Partners to Present Data from Localized Immune Agonist (MP0317), T-cell Engager, and Peptide-MHC Immunotherapy Programs at AACR Annual Meeting
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Molecular Partners Nominates Agnete Fredriksen for Election to Its Board of Directors
March 11, 2021 GMT
Acknowledged innovation leader with deep scientific and business expertise in immunotherapy, oncology and infectious diseases
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / March 11, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced the nomination of Agnete Fredriksen, Ph.D., to the Company’s Board of Directors proposed for election at the 2021 Annual General Meeting on April 21, 2021.
“We are pleased to propose Agnete for election to our Board of Directors during a time of growth and development for Molecular Partners, as we lay the foundations for an infectious diseases portfolio and new technologies for next-generation cancer immunotherapies to fruiti
Molecular Partners AG: Molecular Partners Nominates Agnete Fredriksen for Election to Its Board of Directors
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / March 11, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin
® therapeutics, today
announced the nomination of Agnete Fredriksen, Ph.D., to the Company s Board of Directors proposed for election at the 2021 Annual General Meeting on April 21, 2021. We are pleased to propose Agnete for election to our Board of Directors during a time of growth and development for Molecular Partners, as we lay the foundations for an infectious diseases portfolio and new technologies for next-generation cancer immunotherapies to fruition, said Bill Burns, chairman of the Molecular Partners Board of Directors. We look forward to benefiting from her breadth of expertise across our deepening portfolio as we continue to expand the capabilities of
Molecular Partners Nominates Agnete Fredriksen for Election to Its Board of Directors
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.